Suppr超能文献

粘小管切开联合小梁切开术治疗难治性先天性原发性青光眼。

Viscocanalostomy combined with trabeculotomy for management of refractory primary congenital glaucoma.

机构信息

Glaucoma Service, Farabi Eye Hospital, Tehran, Iran.

Glaucoma Service, Farabi Eye Hospital, Tehran, Iran.

出版信息

J AAPOS. 2022 Jun;26(3):121.e1-121.e6. doi: 10.1016/j.jaapos.2021.12.010. Epub 2022 Apr 14.

Abstract

PURPOSE

To investigate the outcome of viscocanalostomy combined with trabeculotomy (VCO+tbo) in primary congenital glaucoma (PCG) with history of failed trabeculotomy.

METHODS

In this prospective study, VCO+tbo was performed in 75 eyes of 46 patients with PCG who had not responded adequately to one angle surgery. Success was defined as intraocular pressure (IOP) of 6-21 mm Hg and at least 20% IOP drop at the last postoperative visit with (qualified) or without (complete) glaucoma medications.

RESULTS

Patients completed a mean follow-up of 31 ± 11 months. Complete success was achieved in 6 eyes (8%); qualified success, in 38 eyes (51%). In the 44 successfully treated eyes, IOP was reduced from a preoperative mean of 29.0 ± 5.8 to 15.7 ± 2.6 mm Hg, and the number of medications dropped from 2.6 ± 0.9 to 2.0 ± 1.0 (P < 0.001). In univariate analysis, the success rate was lower in patients with neonatal onset disease than subjects whose age at onset was 1-12 months (HR = 0.22; 95% CI, 0.05-0.93; P = 0.039). Children whose disease was first diagnosed after 1 year of age responded better than neonatal onset patients but worse than those with age of onset of 1-12 months; however, the difference was not statistically significant. Hyphema occurred in 27 eyes (36%) on day 1 and resolved spontaneously. Iatrogenic cyclodialysis occurred in one eye, which was surgically repaired after 1 month of treatment with cycloplegic agents.

CONCLUSIONS

In our study cohort, VCO+tbo was associated with successful outcomes in the majority of treated eyes.

摘要

目的

研究伴有小梁切开术失败史的原发性先天性青光眼(PCG)行粘小管切开联合小梁切开术(VCO+tbo)的结果。

方法

在这项前瞻性研究中,对 46 例曾行 1 次抗青光眼手术但眼压控制不佳的 PCG 患者的 75 只眼行 VCO+tbo。成功定义为末次随访时眼压(IOP)为 6-21mmHg,且与(合格)或不(完全)使用降眼压药物相比,IOP 下降至少 20%。

结果

患者平均随访 31±11 个月。6 只眼(8%)获得完全成功,38 只眼(51%)获得合格成功。在 44 只成功治疗的眼中,IOP 从术前的 29.0±5.8mmHg 降至 15.7±2.6mmHg,用药数从 2.6±0.9 降至 2.0±1.0(P<0.001)。单因素分析显示,新生儿期发病患者的成功率低于发病年龄为 1-12 个月的患者(HR=0.22;95%CI,0.05-0.93;P=0.039)。1 岁后发病的患儿的反应优于新生儿期发病的患儿,但比发病年龄为 1-12 个月的患儿差,但差异无统计学意义。27 只眼(36%)第 1 天出现前房积血,自发吸收。1 只眼发生医源性睫状体分离,用睫状肌麻痹剂治疗 1 个月后手术修复。

结论

在我们的研究队列中,VCO+tbo 可使大多数治疗眼获得成功的结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验